気管支喘息に対する点治療の効果：多施設共同無作為化比較試験

X U Huanfang¹, L I Jiashan¹, Yang Li¹

¹Acupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan

|February 25, 2026

まとめ

点治療（PAT）は、気管支喘息患者の喘息増悪を有意に減少させました。この治療法は肺機能も改善し、軽度の副作用が観察されました。

科学分野:

肺学; アレルギー学および免疫学; 呼吸器医学

背景:

気管支喘息のような慢性呼吸器疾患は、患者の生活の質に著しい影響を与える。; 喘息増悪は、医療システムおよび患者に大きな負担をもたらす。; 喘息増悪の効果的な管理戦略が継続的に求められている。

主な方法:

835人の気管支喘息患者を対象とした多施設共同無作為化プラセボ対照試験。; 患者は、2年連続の夏の土用期間中に定期的なPATまたはプラセボPATを受けた。; 主要評価項目：24ヶ月時点でのベースラインからの喘息増悪の変化。二次評価項目には、肺機能検査および薬剤使用が含まれた。

結論:

夏の土用期間中に投与される点治療は、喘息増悪の軽減に効果的である。; PATは、気管支喘息の管理のための治療介入として可能性を示す。; さらなる研究では、PATの長期的な影響および最適な適用プロトコルを検討する可能性がある。

キーワード:

喘息喘息増悪回数点治療無作為化比較試験

さらに関連する動画

05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.5K

04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

1.2K

関連する概念動画

Antiasthma Drugs: β2-Adrenoceptor Agonists

01:25

Antiasthma Drugs: β₂-Adrenoceptor Agonists

1.9K

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

1.9K

01:30

Asthma-IV: Diagnostic and Management

3.2K

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

3.2K

01:26

COPD: Management Using Bronchodilators and Corticosteroids

942

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

942

01:11

Blinding

4.0K

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

4.0K

01:30

Asthma-IV: Nursing Management

3.9K

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...

3.9K

01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.0K

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

2.0K